Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [916]
News [2620]
Articles [112]
Editorials [3]
Conferences [85]
elearning [27]
Results from the phase I ICONIC trial
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Results from the phase I ICONIC trial ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
4 Jun 2018
Economic impact of NGS in non small cell lung cancer
Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA
Economic impact of NGS in non small cell lung cancer ( Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA )
4 Jun 2018
Avelumab in combinations for lung cancer and update from ALEX study
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Avelumab in combinations for lung cancer and update from ALEX study ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
4 Jun 2018
Early results from a 3rd gen EGFR-TKI in advanced NSCLC
Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea
Early results from a 3rd gen EGFR-TKI in advanced NSCLC ( Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea )
3 Jun 2018
Pembrolizumab works better than chemotherapy alone as initial treatment for...
Dr Gilberto Lopes - Sylvester Comprehensive Cancer Center, Miami, USA
Pembrolizumab works better than chemotherapy alone as initial treatment for NSCLC ( Dr Gilberto Lopes - Sylvester Comprehensive Cancer Center, Miami, USA )
3 Jun 2018
Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer...
Dr John Heymach & Prof Richard Schilsky
Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer treatment ( Dr John Heymach & Prof Richard Schilsky )
3 Jun 2018
PD-1 immunotherapy better than chemo alone as first line lung cancer treatment
Dr Gilberto Lopes - Oncoclinicas do Brasil, São Paulo, Brazil
PD-1 immunotherapy better than chemo alone as first line lung cancer treatment ( Dr Gilberto Lopes - Oncoclinicas do Brasil, São Paulo, Brazil )
3 Jun 2018
Web-mediated follow-up via patient-reported outcomes vs. routine surveillance...
Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France
Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in lung cancer patients ( Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France )
2 Jun 2018
Development of blood tests for early lung cancer
Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA
Development of blood tests for early lung cancer ( Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA )
2 Jun 2018
Atezolizumab with chemotherapy improves PFS in squamous NSCLC
Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA
Atezolizumab with chemotherapy improves PFS in squamous NSCLC ( Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA )
2 Jun 2018
Development of blood tests for early lung cancer
Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA
Development of blood tests for early lung cancer ( Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA )
2 Jun 2018
Atezolizumab with chemotherapy improves PFS in squamous NSCLC
Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA
Atezolizumab with chemotherapy improves PFS in squamous NSCLC ( Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA )
2 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation